Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.

about

Acquired aplastic anemia in Korean children: treatment guidelines from the Bone Marrow Failure Committee of the Korean Society of Pediatric Hematology Oncology.

Item

http://www.wikidata.org/entity/Q38740791

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Acquired aplastic anemia in Ko ...... Pediatric Hematology Oncology.

@en

type

Item

label

Acquired aplastic anemia in Ko ...... Pediatric Hematology Oncology.

@en

prefLabel

Acquired aplastic anemia in Ko ...... Pediatric Hematology Oncology.

@en

P1476

Acquired aplastic anemia in Ko ...... Pediatric Hematology Oncology.

@en

P2093

Ho Joon Im

http://www.w3.org/2001/XMLSchema#string

Hoon Kook

http://www.w3.org/2001/XMLSchema#string

Hyoung Jin Kang

http://www.w3.org/2001/XMLSchema#string

Nack-Gyun Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Current concepts in the pathophysiology and treatment of aplastic anemia

Haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.

Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.

P2888

s12185-016-1956-8

P304

380-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-016-1956-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002969214

http://www.w3.org/2001/XMLSchema#string

P698

26894608

http://www.w3.org/2001/XMLSchema#string